Herpes zoster incidence in diabetic patients;Incidencia de herpes zóster en pacientes diabéticos

Anales del Sistema Sanitario de Navarra

Volumn 36, Issue 1, 2013, Pages 57-62

  Aldaz, P ^a,b,c   Diaz J A ^d   Loayssa, J R ^e   Dronda, M J ^a   Osacariz M ^a,c   Castilla, J ^f,g  

^a Centro de Salud de San Juan   (Spain)

^b PAPPS SEMFYC   (Spain)

^c SNAMFAP   (Spain)

^d Centro de Salud del II Ensanche   (Spain)

^e Centro de Salud de Huarte   (Spain)

^f INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Diabetes mellitus; Herpes zoster; Incidence; Spain; Varicella zoster virus

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; HERPES ZOSTER; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; RISK FACTOR; SPAIN;

EID: 84877333116     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1137-66272013000100006     Document Type: Article

References (12)

1. Mueller NH, Gilden DH, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin 2008; 26: 675-697.
2. Cebrian-Cuenca AM, Díez-Domingo J, San Martín M, Puig-Barberá J, Navarro-Pérez J. Epidemiology of herpes zoster infection among patients treated in primary care centres in Valencian Community (Spain). BMC Fam Pract 2010; 6: 11-33.
3. García Cenoz M, Castilla J, Montes Y, Morán J, Salaberria, Elía F et al. Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005-2006. An Sist Sanit Navar 2008; 31: 71-80.
4. Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis 2008; 197: S224-227.
5. Nassaji-Zavareh M, Taheri R, Ghorbani R, Aminian M. Undiagnosed diabetes mellitus in patients with Herpes Zoster. Indian J Dermatol 2008; 53: 119-121.
6. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-2284.
7. Gil A, San-Martín M, Carrasco P, González A. Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine 2004; 22: 3947-3951.
8. Oxman MN. Herpes zoster pathogenesis and cell-mediated immunity and immunosenes-cence. J Am Osteopath Assoc 2009; 109: S13-17.
9. Opstelten W, Van Essen GA, Schellevis F, Verheij TJ, Moons KG. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 2006; 16: 692-695.
10. Okamoto S, Hata A, Sadaoka K, Yamanishi K, Mori Y. Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis 2009; 200: 1606-1610.
11. Heymann AD, Chodick G, Karpati T, Kamer L, Kremer E, Green MS et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008; 36: 226-230.
12. Jih JS, Chen YJ, Lin MW, Chen YC, Chen TJ, Huang YL et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol 2009; 89: 612-616.